Market Research Report
Philippines Radiotherapy Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026
|Published by||Coherent Market Insights||Product code||865078|
|Published||Content info||160 Pages
Delivery time: 2-3 business days
|Philippines Radiotherapy Market - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026|
|Published: May 7, 2019||Content info: 160 Pages||
Radiation therapy or radiotherapy is a cancer treatment therapy, which uses high doses of radiations to kill cancer cells and shrink tumors. Several types of radiotherapies such as external beam radiation therapy, internal beam radiation therapy/ brachytherapy, and systemic radiation therapy are available to combat various types of cancers prevalent, globally. External beam radiation therapy is used to treat various types of cancers, including brain tumors, bladder cancer, and bone cancers. Brachytherapy is often used to treat cancers of the head and neck, breast, cervix, prostate, and eye, while systemic radiation therapy is often used to treat certain types of thyroid cancers using radioactive iodine.
Installment of novel technologically advanced radiotherapy equipment in Philippines for the treatment of various types cancer is expected to drive the Philippines radiotherapy market growth over the forecast period.
For instance, in 2015, the Philippine Gamma Knife Center at Manila's Cardinal Santos Medical Center acquired Elekta's Leksell Gamma Knife Perfexion stereotactic radiosurgery system, an advanced radiosurgery device with high accuracy, which is used for the treatment of brain and neck tumors.
High prevalence of cancers in Philippines is expected to be another factor increasing demand for radiotherapy for its treatment and significantly support Philippines radiotherapy market growth in near future.
As per the Philippine Cancer Society estimates in 2015, around 2,104 people suffered from leukemia, which accounts for 3% of the total cancer cases and around 1,160 people suffered from non-Hodgkin Lymphoma, which accounts for around 2% of all cancer cases
Furthermore, rising geriatric population in Philippines is expected to increase the chances of prostate cancer in males, which in turn is expected to increase demand for novel treatments such as radiotherapy for its treatment. For instance, according to the HelpAge, there were around 5,905,000 old people in Philippines in 2012, which is expected to reach around 23,633,000 by 2050.
"*" marked represents similar segmentation in other categories in the respective section.